|
Linden Bioscience Inc
|
United States |
|
N/A
|
|
|
|
Memory Pharmaceuticals Corp
|
United States |
|
N/A
|
|
|
Mission Bay Capital III
|
|
16 Sep 2019 |
Fund Closing
Active |
|
|
|
Nereus Pharmaceuticals Inc
|
United States |
1 Aug 2007 |
Series D
|
|
|
|
Neuronautics Inc
|
United States |
|
N/A
|
|
|
|
PhaseBio Pharmaceuticals Inc
|
United States |
|
N/A
|
|
|
|
PhysioGenix Inc
|
United States |
|
N/A
|
|
|
|
Plexxikon Inc
|
United States |
|
N/A
|
|
|
|
Prolysis Ltd
|
United Kingdom |
|
N/A
|
|
|
|
Renovar Inc
|
United States |
|
N/A
|
|
|
|
Revivicor Inc
|
United States |
|
N/A
|
|
|
|
Viamet Pharmaceuticals Inc
|
United States |
|
N/A
|
|